NM23-H1 and Colorectal Cancer Staging
Author Information
Author(s): PY Cheah, X Cao, KW Eu, F Seow-Choen
Primary Institution: Singapore General Hospital
Hypothesis
Is NM23-H1 immunostaining correlated with tumour stage, overall survival, and disease recurrence in colorectal carcinomas?
Conclusion
NM23-H1 expression is inversely correlated with tumour staging but does not predict overall survival or disease recurrence in colorectal cancer.
Supporting Evidence
- NM23-H1 expression was significantly higher in early-stage colorectal cancer compared to late-stage.
- NM23-H1 expression did not correlate with overall survival or disease recurrence.
- The study included a total of 141 patients with colorectal cancer.
Takeaway
This study found that a protein called NM23-H1 is more common in early-stage colorectal cancer but doesn't help predict if someone will survive or have their cancer come back.
Methodology
The study used immunostaining on 141 paraffin-embedded surgical specimens and analyzed the data using chi-square analysis.
Limitations
The study may not be generalizable beyond the Singapore population, and the sample included a majority of moderately differentiated tumors.
Participant Demographics
53 women and 88 men, predominantly Chinese, aged between 50 and over 71.
Statistical Information
P-Value
0.0004
Statistical Significance
p=0.0004
Want to read the original?
Access the complete publication on the publisher's website